Published today in the prestigious journal Lancet Oncology, data from Know Your Tumor shows for the first time that pancreatic cancer patients who are able to go on therapies that match their tumor biology live an average of one year longer compared to patients who don’t. Read more . . .
Know Your Tumor was created to understand the unique differences in each patient’s tumor – and to determine whether these differences can impact which treatment options may work best for each patient. Using results from testing a patient’s tumor or genetic makeup to guide treatment decisions is known as precision medicine.